VILLAPHARM LIMITEDActive

Company number 03259980Private limited companyIncorporated 1996
⚠ Confirmation statement overdue. It was due on 12 Oct 2026.

Key figures

£233,549+10.2%
Net assets 2024/25
+14.4%
Average annual growth 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, VILLAPHARM LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand1,43669,51527,71648,2121,690
Total assets422,898510,724547,870586,620617,409
Total liabilities—————
Net assets / total equity135,572166,472192,556211,977233,549
Average number of employees1561097

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: VILLAPHARM LIMITED

Company

VILLAPHARM LIMITED is a private limited company registered with Companies House under company number 03259980. It was incorporated on 2 Oct 1996. Its status is active. The registered office is in Ipswich (IP9). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were £233,549, up 10.2% on the previous year. Cash at bank and in hand was £1,690. The company had an average of 7 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 of 4 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 12 Oct 2026.